XML 32 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Note 7 - Investments in Joint Ventures
12 Months Ended
Aug. 31, 2025
Notes to Financial Statements  
Equity Method Investments and Joint Ventures Disclosure [Text Block]

7.

INVESTMENTS IN JOINT VENTURES

 

The consolidated financial statements of the Company’s foreign joint ventures are initially prepared using the accounting principles accepted in the respective joint ventures’ countries of domicile. Amounts related to foreign joint ventures reported in the below tables and the accompanying consolidated financial statements have subsequently been adjusted to conform with U.S. GAAP in all material respects. All material profits on sales recorded that remain on the consolidated balance sheet from the Company to its joint ventures and from joint ventures to other joint ventures have been eliminated for financial reporting purposes.

 

Financial information from the audited and unaudited financial statements of the Company’s joint ventures in Germany, Excor Korrosionsschutz – Technologien und Produkte GmbH (EXCOR), France, ACOBAL SAS (Acobal), Finland, Zerust OY and all the Company’s other joint ventures are summarized as follows:

 

    As of August 31, 2025  
    TOTAL    

EXCOR

    Acobal    

Zerust OY

   

Other

 

Current assets

  $ 60,062,085     $ 29,870,525     $ 6,971,262     $ 3,029,614     $ 20,190,684  

Total assets

    69,815,251       36,941,008       7,900,298       3,313,909       21,660,036  

Current liabilities

    11,743,525       2,391,029       2,660,430       719,172       5,972,894  

Noncurrent liabilities

    336,557    

              336,557  

Joint ventures’ equity

    57,735,169       34,549,979       5,239,868       2,594,737       15,350,585  

NTIC’s share of joint ventures’ equity

    28,611,777       17,274,991       2,619,932       1,297,358       7,419,496  

NTIC’s share of joint ventures’ undistributed earnings

    27,667,432       17,244,086       2,619,932       1,277,358       6,526,056  

 

   

Fiscal Year Ended August 31, 2025

 
   

TOTAL

   

EXCOR

   

Acobal

   

Zerust OY

   

Other

 

Net sales

  $ 91,236,272     $ 32,909,789     $ 11,721,152     $ 4,831,258     $ 41,774,073  

Gross profit

    39,460,739       17,637,075       4,500,635       2,976,462       14,346,567  

Net income

    7,081,482       3,325,785       1,418,240       964,653       1,372,804  

NTIC’s share of equity in income of joint ventures

    3,539,057       1,664,532       708,333       483,754       682,436  

NTIC’s dividends received from joint ventures

    1,566,946    

      635,528       382,613       548,805  

 

   

As of August 31, 2024

 
   

Total

   

EXCOR

   

OTHER

 

Current assets

  $ 56,420,503     $ 26,234,664     $ 30,185,839  

Total assets

    64,183,071       31,513,288       32,669,783  

Current liabilities

    12,553,716       2,221,726       10,331,990  

Noncurrent liabilities

    323,199             323,199  

Joint ventures’ equity

    51,306,156       29,291,562       22,014,594  

NTIC’s share of joint ventures’ equity

    25,397,287       14,645,783       10,751,504  

NTIC’s share of joint ventures’ undistributed earnings

    23,645,685       14,614,878       9,030,807  

 

   

Fiscal Year Ended August 31, 2024

 
   

Total

   

EXCOR

   

OTHER

 

Net sales

  $ 95,940,014     $ 35,720,889     $ 60,219,125  

Gross profit

    41,247,036       18,288,258       22,958,778  

Net income

    8,450,411       4,599,088       3,851,323  

NTIC’s share of equity in income of joint ventures

    4,223,296       2,299,274       1,924,022  

NTIC’s dividends received from joint ventures

    2,997,164       1,624,950       1,372,214